WO2021023600A1 - Combination product for helping maintain the natural defenses of the organism and aiding with recovery - Google Patents

Combination product for helping maintain the natural defenses of the organism and aiding with recovery Download PDF

Info

Publication number
WO2021023600A1
WO2021023600A1 PCT/EP2020/071443 EP2020071443W WO2021023600A1 WO 2021023600 A1 WO2021023600 A1 WO 2021023600A1 EP 2020071443 W EP2020071443 W EP 2020071443W WO 2021023600 A1 WO2021023600 A1 WO 2021023600A1
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
combination product
spirulina
vitamins
bacterial strain
Prior art date
Application number
PCT/EP2020/071443
Other languages
French (fr)
Inventor
Marilyn GENTILHOMME
France VIROUX
Original Assignee
Urgo Recherche Innovation Et Developpement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urgo Recherche Innovation Et Developpement filed Critical Urgo Recherche Innovation Et Developpement
Publication of WO2021023600A1 publication Critical patent/WO2021023600A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415Pyridoxine, i.e. Vitamin B6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51Thiamines, e.g. vitamin B1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525Isoalloxazines, e.g. riboflavins, vitamin B2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/748Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • the present invention relates to a combination product comprising as active substances, at least royal jelly, spirulina, vitamin C, vitamin D3, vitamins of group B as well as less a bacterial strain to help maintain the body's natural defenses and get back in shape.
  • the invention relates to the use of a combination product as defined above for the prevention and / or treatment of infectious pathologies, whether of viral or bacterial origin.
  • a viral disease or virosis, is a disease initiated by a virus and its spread throughout the body (and at the expense of the body).
  • RNA viruses can transform very quickly and overcome the host's defenses as shown by influenza (influenza). Viral illnesses are all illnesses, mild or severe, caused by a virus. They can be transmitted and take the form of an epidemic. There are many, many viral diseases. Among them, the common cold, angina, influenza, chickenpox, measles, smallpox, hepatitis B, AIDS ...
  • Viral diseases are transmitted from person to person through saliva, promiscuity or sexual relations. More rarely, a viral illness can be contracted from the consumption of foods of animal origin. Each virus attacks a specific part of the body. It is this action that will allow the identification of the viral disease.
  • a viral disease does not appear immediately after exposure. An incubation period can be noticed. This incubation lasts a few hours for an influenza and a few months for other viruses.
  • the manifestations of a viral illness are fever, headache, muscle aches, fatigue and lack of tone. Depending on the severity of the pathology, the general state of fatigue can be disabling. Some viral diseases have skin lesions as symptoms, such as chickenpox, measles, rubella or herpes.
  • Bacterial disease (or bacteriosis) is an infectious disease caused by bacteria. Bacterial diseases are very numerous in human pathology.
  • infectious pathologies mention may be made, for example, of tonsillitis, nasopharyngitis, gastroenteritis, seasonal flu, colds, sinusitis, cough, bronchitis, sore throats, etc. ..
  • the immune system is a complex system which protects the organism from external aggressions, be they viruses, bacteria or parasites. For this, it involves thousands of cells produced mainly in the bone marrow which then specialize in the thymus, spleen, lymph nodes, then circulate in the blood.
  • the thymus Located behind the breastbone, the thymus is an extremely important gland in the development of the immune system: it positively selects cells (T lymphocytes) capable of recognizing what is foreign to the organism (the non-self. ), while it removes those that could react against our own constituents (the self).
  • Merck's Bion 3 Defense product contains ferments (Lactobacillus gasseri PA 16/8, Bifidobacterium bifidum MF 20/5, Bifidobacterium longum SP 07/3), vitamins: A, Bl, B2, B3, B5, B6, B8, B9, B12, C, D, E and minerals : iodine, iron, zinc, selenium, chromium, manganese, magnesium.
  • the combination product of the present invention helps to maintain the body's natural defenses by stimulating and strengthening the immunity of individuals. It also helps the body to get back in shape.
  • the product of the present invention is without side effects or addiction.
  • the product according to the present invention makes it possible to increase resistance against fatigue, in particular thanks to the presence of royal jelly, vitamin C and spirulina, to increase the body's resistance to external aggressions. , especially thanks to spirulina and the bacterial strain, and to increase physical resistance, in particular thanks to vitamin D which participates in bone growth.
  • the product according to the present invention therefore has the advantage of combining a bacterial strain, a “superfood”, bee products and vitamins in a single intake.
  • the product of the present invention is preferably in the form of vials allowing optimum preservation of the composition.
  • the present invention relates to a combination product, comprising as active substances at least:
  • group B vitamins are chosen from group B vitamins are chosen from vitamin B1, B2 and B6 or a combination of these vitamins.
  • the bacterial strain is a lactic acid bacterium, more preferably of the genus Lactobacillus rhamnosus.
  • the present invention also relates to a combination product, comprising as active substances at least:
  • the combination product according to the invention comprises, in addition to royal jelly, spirulina, vitamin C, vitamin D3, vitamins of group B as well as at least a bacterial strain, as active substances:
  • Plants or plant extracts such as for example astragalus, ginseng, guarana or eleutherococcus
  • Vitamins and minerals such as for example vitamin A, vitamin E, and / or zinc, iron or selenium
  • the combination product according to the invention may be in the form of a single (or combined) composition containing at least as active substances:
  • the combination product of the invention is characterized in that the royal jelly, spirulina, vitamin C, vitamin D3, group B vitamins as well as the bacterial strain are administered under the shape of a flask comprising (1) a dry part which comprises: from 20 to 300 mg, preferably 30 to 100 mg of vitamin C from 0.05 to 8 mg, preferably 0.2 to 6 mg of vitamin B1 from 0.05 to 8 mg of preferably 0.2 to 6 mg of vitamin B2 from 0.05 to 8 mg preferably 0.2 to 6 mg of vitamin B6 from 0.5 to 20 pg, preferably 1 to 10 pg of vitamin D3 from 0.5 to 5 billion colony forming units, preferably 0.75 to 2 billion bacterial strain colony forming units
  • the combination product is characterized in that the active ingredients (i), (ii), (iii), (iv), (v) and (vi) are in a medium suitable for oral administration.
  • the combination product comprises two forms, a dry and a liquid, the two forms being mixed just before ingestion. This makes it possible to improve the stability of all the active ingredients entering into the composition according to the invention.
  • the Applicant has demonstrated that the combination of at least, (i) royal jelly, (ii) spirulina, (iii) vitamin C, (iv) vitamin D3, (v) group B vitamins, (vi) at least one bacterial strain, exhibited a synergistic effect to help maintain the body's natural defenses and regain shape.
  • Royal jelly is the secretion product of the cephalic glandular system (hypopharyngeal glands and mandibular glands) of worker bees, between the fifth and the fourteenth day of their existence (workers who then bear the name of nurse). Royal jelly contains lipids (4.5%), carbohydrates (14.5%), proteins (13%) and water (approximately 66%).
  • Royal jelly contains a considerable proportion of protein, amino acids, lipids, vitamins and sugars, and is often considered to have various nutritional and medicinal benefits in humans.
  • composition according to the present invention comprises from 50 to 500 mg, preferably from 100 to 300 mg of royal jelly.
  • Spirulina is an algae that has existed as it is for more than 3 billion years. So named because of its spiral shape, it belongs to the family of cyanobacteria or blue-green microalgae. There are nearly 1,500 species of blue algae, and 36 species of spirulina are edible. The main species currently available on the market is Spirulina platensis. First cultivated mainly in California and Hawaii, spirulina is now produced in a controlled manner all over the world where the climate allows it: Chile, China, Cuba, India, West Africa, Greece (in geothermal greenhouses), etc. In the market, spirulina is generally in the form of a dehydrated blue-green powder, in bulk or in capsules.
  • Spirulina low in calories, contains a wealth of nutrients in a very small volume. Its content can however vary according to its geographical origin, but also according to the cultivation, drying and grinding processes. [47] Spirulina contains 55% to 70% protein of excellent quality (proportion of amino acids and optimal digestibility), or 2.5 g to 3.5 g of protein per 5 g of powder.
  • Spirulina is an exceptional source of various carotenoids (mainly beta-carotene, but also cryptoxanthin, lutein, zeaxanthin, etc.), ie around 22 mg / 5 g. In particular, it provides an astronomical amount of beta-carotene, ie from 12,000 III to 25,000 III per 5 g of powder.
  • spirulina is rich in phycocyanin, the only natural blue pigment that can serve as a food coloring and which is attributed a significant antioxidant activity. It also contains chlorophyll and small amounts of several minerals.
  • composition according to the present invention comprises from 50 to 500 mg, preferably from 100 to 300 mg of spirulina. Its quantities of spirulina represent in plant equivalent from 500 to 5000 mg, preferably 1000 to 3000 mg.
  • Vitamin C is a water soluble, heat and light sensitive vitamin that plays an important role in the metabolism of humans and many other mammals. Chemically speaking, it is L-ascorbic acid, one of the stereoisomers of ascorbic acid, and its salts, the ascorbates. The most common are sodium ascorbate and calcium ascorbate.
  • Vitamin C is an enzymatic cofactor involved in a number of physiological reactions (hydroxylation). It is required in the synthesis of collagen and red blood cells and contributes to the immune system. It also plays a role in the metabolism of iron as a promoter of its absorption; its use is therefore not recommended in patients with an iron overload and particularly hemochromatosis. In oxidized form (dehydroascorbic acid), it crosses the blood-brain barrier to access the brain and several organs with a high concentration of vitamin C.
  • composition according to the present invention comprises 20 to 300 mg, preferably 30 to 100 mg of vitamin C.
  • Thiamine or vitamin B1 is a metabolic precursor of thiamine pyrophosphate (TPP), a coenzyme essential for certain decarboxylases.
  • TPP thiamine pyrophosphate
  • thiamine is a water-soluble vitamin from the family of B vitamins that they must find in their diet.
  • it is synthesized by bacteria, plants and fungi. It is essential for the transformation of carbohydrates into energy by the Krebs cycle and is necessary for the proper functioning of the nervous system and muscles. It is in fact essential for the transformation of pyruvate produced by glycolysis and toxic for the nervous system.
  • composition according to the present invention from 0.05 to 8 mg, preferably 0.2 to 6 mg of vitamin B1.
  • Vitamin B2 corresponding to riboflavin, or lactoflavin, is a water-soluble vitamin required for the synthesis of flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN), two essential cofactors of flavoproteins.
  • FAD flavin adenine dinucleotide
  • FMN flavin mononucleotide
  • Vitamin B2 plays an important role in converting simple foods (carbohydrates, fats and proteins) into energy. It is involved in the repair metabolism of muscles.
  • Riboflavin is found naturally in asparagus, popcorn, bananas, persimmons, okra, Swiss chard, cheese, milk, yogurt, meat, eggs, fish and beans. greens, each of which contains at least 0.1 mg of vitamin B per 85-300g. Other sources are green leafy vegetables, liver, kidneys, legumes, tomatoes, yeasts, mushrooms and almonds.
  • composition according to the present invention comprises from 0.05 to 8 mg, preferably 0.2 to 6 mg of vitamin B2.
  • Vitamin B6 is a water-soluble vitamin that exists in several forms, pyridoxal phosphate being its biologically active form, as a cofactor involved in several reactions of amino acid metabolism, including transaminations, deaminations and decarboxylations. Pyridoxal phosphate is also involved in the reaction of hydrolysis of glycogen to glucose.
  • Vitamin B6 is known in seven different forms, interconvertible between them except the last one:
  • PN pyridoxine
  • PBP pyridoxal phosphate
  • PA 4-pyridoxic acid
  • Vitamin B6 participates in the transformation of tryptophan into vitamin B3, and in the metabolism of lipids and amino acids (decarboxylation and transamination). Pyridoxal phosphate allows the conversion of glycogen into glucose (Glucose-1-Phospate) by Glycogen phosphorylase.
  • Vitamin B6 also participates in the biosynthesis of serotonin.
  • cystine Associated with cystine, it is administered to facilitate the development of integuments (hair, nails, etc.).
  • composition according to the present invention comprises from 0.05 to 8 mg, preferably 0.2 to 6 mg of vitamin B6.
  • Cholecalciferol is a form of vitamin D, also called vitamin D3.
  • Vitamin D3 is a secosteroid rather related to testosterone, cholesterol and cortisol.
  • Vitamin D has a dual origin: it is provided by food and synthesized by the body in the skin under the action of UVB rays from the sun.
  • People with very little exposure to the sun may have varying degrees of vitamin D deficiency. People with fair skin synthesize vitamin D faster than those with dark skin, and therefore need a long period of time. shorter exposure to convert vitamin D precursors produced by the liver into vitamin D.
  • the amount of vitamin D that the skin can produce is limited; prolonged exposure to sunlight (more than 30 minutes for a fair-skinned person, up to three hours for a dark-skinned person) does not increase the amount of cholecalciferol produced by the body.
  • Vitamin D produced by the skin is stored in the liver, muscle and fatty tissue and used on demand during winter periods.
  • vitamin D2 or ergocalciferol produced by plants and vitamin D3 or cholecalciferol produced by animals, as well as by certain lichens. In humans, these two forms are converted to 1,25-dihydroxyvitamin D (commonly known as vitamin D), their main active metabolite.
  • vitamin D The essential function of vitamin D is to increase the absorption capacity of the intestine for calcium and phosphorus which allows:
  • vitamin D deficiency The clinical signs of vitamin D deficiency are: osteomalacia and rickets in the bone, decreased muscle tone, tetany attacks and convulsions (related to hypocalcemia) and sometimes anemia.
  • vitamin D deficiency constitutes a favorable ground for bone loss (therefore osteoporosis), and depression (as confirmed by a Dutch study mentioned in Archives of General Psychiatry (May 2008)) .
  • vitamin D3 The recommended nutritional intake of vitamin D was defined considering that endogenous production covers 50 to 70% of the daily requirements of this vitamin.
  • a limited number of foods contain significant amounts of vitamin D. Indeed, these levels are closely linked to the presence of fat in foods.
  • the best sources of vitamin D are fatty sea fish, whatever their method of preparation and conservation (boiling, smoking, canning, grilling): herring, salmon, sardines, mackerel for example. Egg yolks, dairy products, soy and its derivatives (tofu and soy milk for example) and certain mushrooms (with great differences depending on the variety) are also sources of vitamin D.
  • Low amounts of vitamin D are also provided by meats, offal and pâtés. Lean fish (ray, sole, hake ...) do not have them.
  • Some lichens also produce cholecalciferol (vitamin D3), and are used to produce plant food supplements with this vitamin.
  • composition according to the present invention comprises from 0.5 to 20 pg, preferably 1 to 10 pg of vitamin D3.
  • probiotics are living microorganisms (bacteria or yeasts) which, added as a supplement to certain food products such as yogurt or cereals, and ingested in adequate quantities, are believed to confer a health benefit on the body. the healthy host.
  • the human gut microbiota (preferred term to that of microflora) comprises 800 to 1000 known microbial species15 and its diversity in dominant species is unique to each. Quantitatively, it is very stable over time (for a given individual over 2 months to 2 years), although it is not possible to define an intestinal microbiota of the human species by the profile of dominant species. . It is a consortium adapted to the host, stable, that is to say resistant to modification.
  • lactic acid bacteria are the most widely used. They are natural hosts for the human gut microbiota.
  • probiotics are based on a symbiosis effect by allowing the intestinal microbiota to retain a predominantly non-pathogenic dominance. They modulate the activity of the intestinal immune system, strengthening general immunity when it is weak, for example in children, immature (newborns) or the elderly. Conversely, they could decrease the over-activation of the immune system, in the event of allergies or inflammatory bowel diseases, thus improving the barrier function of the intestinal mucosa by increasing the production and quality of mucus and / or IgA-type antibodies. They have a direct anti-pathogenic effect (by competition) by limiting the adhesion of pathogens to the intestinal walls.
  • the bacterial strain is a lactic acid bacterium, more preferably of the genus Lactobacillus rhamnosus.
  • Lactobacillus Rhamnosus strain (ATCC n. 53103) will be preferred.
  • composition according to the present invention comprises from 0.5 to 5 billion colony-forming units, preferably from 0.75 to 2 billion colony-forming units of a bacterial strain.
  • Physiologically acceptable medium preferably from 0.75 to 2 billion colony-forming units of a bacterial strain.
  • a physiologically acceptable medium is a medium having no toxic or detrimental effect under the conditions of use and inert with respect to the active ingredients of the combination product.
  • a medium can, for example, comprise different adjuvants according to its therapeutic or cosmetic purpose, such as, without limitation, flavors, colorants, fillers, diluents, wetting or suspending agents, etc.
  • Such media can also allow immediate, modified or delayed release of one or other of the active ingredients.
  • the physiologically acceptable medium can be composed of texturizers, colorants, flavors, sugar or sugars.
  • texturizers is understood to mean the compounds which modify the texture of the products in which they are incorporated.
  • texturizers are: guar and carob flour; gum arabic, xanthan and gellan; carrageenans; starches (native or modified); microcrystalline cellulose; gelatin; pectin; alginates (E400 to E405); agar-agar; and their mixtures.
  • dye is understood to mean compounds of natural or synthetic origin capable of conferring on themselves a coloring on the composition. Examples of food colors are known in Europe under the codes E100 to E180. In the context of the present invention, only the liquid part contains a dye. Preferably this colorant is a caramel colorant.
  • aromas is understood to mean compounds of natural or synthetic origin which are capable on their own of modifying the taste of the composition.
  • flavors are apricot, pineapple, banana, black currant, cherry, lemon, lime, strawberry, raspberry, passion fruit, tangerine, mint, orange , pistachio, pear, licorice, rose, anise, blueberry, cinnamon, ginger, grapefruit, apple, kiwi, lychee, melon, coconut, peach, currant, guava, grenadine, mango, blackberry, papaya, vanillin, natural vanilla extract, essential oils and mixtures thereof.
  • this aroma is a white peach aroma.
  • sucrose or sugars is understood to mean any sweetening carbohydrate or any sweetening agent, preferably glucose syrup, sucrose, glucose, fructose, invert sugar, honey, maltose, or theirs. mixtures.
  • sugars used are fructose, honey and sucralose.
  • composition according to the present invention also contains preservatives.
  • the combination product is in the form of a vial combining a liquid form and a dry form.
  • dry form is understood to mean a form free from liquid, exhibiting a residual moisture level, when it is measured by the loss on drying method, of less than 20%, preferably less than 10%, more preferably less than 5%.
  • liquid form means a syrup, an emulsion or a solution.
  • any additional active having a nutritional interest and / or helping to maintain the natural defenses of the organism can also be added to the products of combination of the invention in pharmaceutical or cosmetic form.
  • the combination product may comprise, by way of example, vitamins, mineral salts, essential amino acids, essential fatty acids, trace elements, various plant extracts, fibers, antioxidants, flavonoids.
  • such an additional active agent can be intended to enhance the desired effect as described above.
  • water-soluble vitamins and fat-soluble vitamins examples include vitamin B3 (nicotinic acid) also called vitamin PP (Pellagra Preventive), vitamin B5 (pantothenic acid), vitamin B8 or H (biotin) , vitamin B9 (folic acid) and vitamin B12 (cobalamin).
  • vitamin B3 nicotinic acid
  • PP Pantothenic acid
  • vitamin B8 or H biotin
  • vitamin B9 folic acid
  • vitamin B12 cobalamin
  • fat-soluble vitamins present in the syrupy product prepared according to the invention are in particular: vitamin A (retinol), vitamin E (mixture of tocopherols and tocotrienols) and vitamin K (phylloquinone).
  • curcuminoids such as curcuminoids; carotenoids, especially chosen from beta.-carotene, astaxanthin, zeaxanthin, lutein or compounds containing them, such as goji berries; polyphenol compounds, flavonoids such as catechins; proanthocyanidins, anthocyanins, OPCs (procyanidol oligomers); ubiquinones; coffee extracts containing polyphenols and / or diterpenes; chicory extracts; extracts of ginkgo biloba; grape extracts rich in proanthocyanidins; chilli extracts; soy extracts; Cocoa ; the grenade ; the Emblica; CoenzymeQ10; selenium,
  • sulfur-containing amino acids such as precursors of glutathione, amino acids of selenium, citrulline,
  • a combination product according to the invention is administered orally.
  • the combination product according to the invention is in the form of a vial comprising two parts, one part containing the liquid form and the closure device of this type of vial is adapted to contain the dry part which , when opening the vial, will be released into the vial which contains the liquid part.
  • Vitamins C, B1, B2, B6 and D3 are incorporated into the composition in the form of a solution. They are present in an amount of 40 mg, 0.80 mg, 1.10 mg, 0.70 mg and 5pg respectively.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Animal Husbandry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The invention relates to a combination product comprising, as active substances, at least royal jelly, spirulina, vitamin C, vitamin D3, B group vitamins, and at least one bacterial strain to help maintain the natural defenses of the organism and aid with recovery. The invention further relates to the use of a combination product as defined above for the prevention and/or treatment of infectious viral and bacterial diseases.

Description

Description Description
Titre de l'invention : Produit de combinaison pour aider au maintien des défenses naturelles de l'organisme et à retrouver la forme Title of the invention: Combination product to help maintain the body's natural defenses and regain shape
[1]DOMAINE TECHNIQUE [1] TECHNICAL FIELD
[2]La présente invention a pour objet un produit de combinaison comprenant à titre de substances actives, au moins de la gelée royale, de la spiruline, de la vitamine C, de la vitamine D3, des vitamines du groupe B ainsi qu'au moins une souche bactérienne pour aider au maintien des défenses naturelles de l'organisme et à retrouver la forme. L'invention concerne enfin l'utilisation d'un produit de combinaison tel que précédemment défini pour la prévention et/ou le traitement des pathologies infectieuses, qu'elles soient d'origine virale ou bactérienne. [2] The present invention relates to a combination product comprising as active substances, at least royal jelly, spirulina, vitamin C, vitamin D3, vitamins of group B as well as less a bacterial strain to help maintain the body's natural defenses and get back in shape. Finally, the invention relates to the use of a combination product as defined above for the prevention and / or treatment of infectious pathologies, whether of viral or bacterial origin.
[3] ARRI ERE PLAN [3] BACKGROUND
[4]Certaines périodes, comme la croissance, les phases de convalescence, le froid sollicitent et fatiguent l'organisme. Parfois, une alimentation déséquilibrée ou un manque d'appétit ne couvrent pas à 100% les besoins journaliers. Les enfants ou les adultes sont alors plus susceptibles de présenter des signes de fatigue et/ou de contracter des infections, qu'elles soient d'origine virale ou bactérienne. [4] Certain periods, such as growth, convalescence and cold stress and tire the body. Sometimes an unbalanced diet or lack of appetite does not meet your daily needs 100%. Children or adults are then more likely to show signs of fatigue and / or to contract infections, whether viral or bacterial.
[5]Une maladie virale, ou virose, est une maladie déclenchée par un virus et sa propagation dans l'organisme (et aux dépens de l'organisme). [5] A viral disease, or virosis, is a disease initiated by a virus and its spread throughout the body (and at the expense of the body).
[6] Les virus à ARN peuvent se transformer très rapidement et déjouer les défenses de l'hôte comme le montre celui de la grippe (influenza). Les maladies virales sont toutes les maladies, bénignes ou graves, causées par un virus. Elles peuvent se transmettre et prendre la forme d'une épidémie. Il existe de très nombreuses maladies virales. Parmi elles, le rhume, l'angine, la grippe, la varicelle, la rougeole, la variole, l'hépatite B, le sida... [6] RNA viruses can transform very quickly and overcome the host's defenses as shown by influenza (influenza). Viral illnesses are all illnesses, mild or severe, caused by a virus. They can be transmitted and take the form of an epidemic. There are many, many viral diseases. Among them, the common cold, angina, influenza, chickenpox, measles, smallpox, hepatitis B, AIDS ...
[7]Les maladies virales se transmettent d'individu en individu grâce à la salive, à la promiscuité ou aux relations sexuelles. Plus rarement, une maladie virale peut être contractée lors de la consommation d'aliments d'origine animale. Chaque virus attaque une partie bien précise de l'organisme. C'est cette action qui permettra l'identification de la maladie virale. [7] Viral diseases are transmitted from person to person through saliva, promiscuity or sexual relations. More rarely, a viral illness can be contracted from the consumption of foods of animal origin. Each virus attacks a specific part of the body. It is this action that will allow the identification of the viral disease.
[8]Une maladie virale ne se déclare pas dès l'exposition. Une période d'incubation peut être remarquée. Cette incubation dure quelques heures pour une grippe et quelques mois pour d'autres virus. [9]Les manifestations d'une maladie virale sont la fièvre, les maux de tête, les courbatures, la fatigue et le manque de tonus. Selon la gravité de la pathologie, l'état de fatigue général peut être invalidant. Certaines maladies virales ont pour symptômes les lésions cutanées, c'est le cas de la varicelle, la rougeole, la rubéole ou l'herpès. [8] A viral disease does not appear immediately after exposure. An incubation period can be noticed. This incubation lasts a few hours for an influenza and a few months for other viruses. [9] The manifestations of a viral illness are fever, headache, muscle aches, fatigue and lack of tone. Depending on the severity of the pathology, the general state of fatigue can be disabling. Some viral diseases have skin lesions as symptoms, such as chickenpox, measles, rubella or herpes.
[10]D'autres maladies virales comme le virus du sida ou la poliomyélite ne peuvent pas être soignées. Une prise en charge précoce du patient lui assure une espérance et une qualité de vie optimisée. [10] Other viral diseases such as the AIDS virus or polio cannot be cured. Early treatment of the patient ensures an optimized life expectancy and quality of life.
[11]Une maladie bactérienne (ou bactériose) est une maladie infectieuse causée par une bactérie. Les maladies bactériennes sont très nombreuses en pathologie humaine. [11] Bacterial disease (or bacteriosis) is an infectious disease caused by bacteria. Bacterial diseases are very numerous in human pathology.
[12]Parmi les pathologies infectieuses, on peut citer à titre d'exemple les angines, les rhinopharyngites, la gastro-entérite, la grippe saisonnière, les rhumes, les sinusites, la toux, les bronchites, les maux de gorges, etc... [12] Among the infectious pathologies, mention may be made, for example, of tonsillitis, nasopharyngitis, gastroenteritis, seasonal flu, colds, sinusitis, cough, bronchitis, sore throats, etc. ..
[13]Le système immunitaire est un système complexe, qui protège l'organisme des agressions extérieures, qu'il s'agisse de virus, de bactéries ou de parasites. Pour cela, il met en jeu des milliers de cellules produites essentiellement dans la moelle osseuse qui se spécialisent ensuite dans le thymus, la rate, les ganglions lymphatiques, puis circulent dans le sang. [13] The immune system is a complex system which protects the organism from external aggressions, be they viruses, bacteria or parasites. For this, it involves thousands of cells produced mainly in the bone marrow which then specialize in the thymus, spleen, lymph nodes, then circulate in the blood.
[14]Situé derrière le sternum, le thymus est une glande extrêmement importante dans le développement du système immunitaire : il sélectionne de façon positive des cellules (les lymphocytes T) capables de reconnaître ce qui est étranger à l'organisme (le non- soi), tandis qu'il supprime celles qui pourraient réagir contre nos propres constituants (le soi). [14] Located behind the breastbone, the thymus is an extremely important gland in the development of the immune system: it positively selects cells (T lymphocytes) capable of recognizing what is foreign to the organism (the non-self. ), while it removes those that could react against our own constituents (the self).
[15]Une bonne immunité naturelle permet d'éliminer sans traitement bon nombre de ces pathologies. Afin d'aider l'organisme à maintenir ces défenses naturelles, la Demanderesse a mis au point un produit de combinaison comprenant à titre de substances actives, au moins de la gelée royale, de la spiruline, de la vitamine C, de la vitamine D3, des vitamines du groupe B ainsi qu'au moins une souche bactérienne. [15] Good natural immunity makes it possible to eliminate many of these pathologies without treatment. In order to help the body maintain these natural defenses, the Applicant has developed a combination product comprising, as active substances, at least royal jelly, spirulina, vitamin C, vitamin D3. , B vitamins as well as at least one strain of bacteria.
[16]ll existe sur le marché un certain nombre de produits pour aider au maintien des défenses naturelles de l'organisme. Parmi ces produits, on peut citer à titre d'exemple Immunité, de Bio Ponroy qui contient : de l'extrait d'astragale, éleuthérocoque et échinacée. Immunité Fort de Nutrigée, qui contient : Andrographis, griffe du chat, pépins de pamplemousse, maca, noix de cola et éleuthérocoque, Vitamine C et D3 naturelles, Cuivre et zinc. Le produit Defatyl Energy Plus Énergie Et Immunité (de Defatyl) est à base de L-carnitine, taurine, vitamine B6, vitamine B12, vitamine Bl, vitamine B2, vitamine B9. Le produit Bion 3 Défense de Merck contient quant à lui des ferments (Lactobacillus gasseri PA 16/8, Bifidobacterium bifidum MF 20/5, Bifidobacterium longum SP 07/3), des vitamines : A, Bl, B2, B3, B5, B6, B8, B9, B12, C, D, E et des minéraux : iode, fer, zinc, sélénium, chrome, manganèse, magnésium. [16] There are a number of products on the market to help maintain the body's natural defenses. Among these products, mention may be made, by way of example, of Immunité, from Bio Ponroy which contains: extract of astragalus, eleutherococcus and echinacea. Immunity Strong of Nutrigée, which contains: Andrographis, cat's claw, grapefruit seeds, maca, cola nuts and eleutherococcus, natural Vitamin C and D3, Copper and zinc. The product Defatyl Energy Plus Energy And Immunity (from Defatyl) is based on L-carnitine, taurine, vitamin B6, vitamin B12, vitamin Bl, vitamin B2, vitamin B9. Merck's Bion 3 Defense product contains ferments (Lactobacillus gasseri PA 16/8, Bifidobacterium bifidum MF 20/5, Bifidobacterium longum SP 07/3), vitamins: A, Bl, B2, B3, B5, B6, B8, B9, B12, C, D, E and minerals : iodine, iron, zinc, selenium, chromium, manganese, magnesium.
[17] Il existe également des produits aidant l'organisme à rester en forme. [17] There are also products that help the body stay in shape.
[18]On peut citer à titre d'exemple le produit Vitalité 4G dynamisant Shot des Laboratoires Forté Pharma qui contient du ginseng, du guarana, du gingembre, de la gelée royale, de l'acérola et de la vitamine C. [18] We can cite as an example the product Vitality 4G energizing Shot from Forté Pharma Laboratories which contains ginseng, guarana, ginger, royal jelly, acerola and vitamin C.
[19]Aucun des produits proposés ne contient l'association objet de la présente invention. [19] None of the products offered contains the combination which is the subject of the present invention.
[20]Ces produits n'apportent pas entière satisfaction en termes d'aide au maintien des défenses naturelles de l'organisme et de maintien en forme de l'organisme. [20] These products are not entirely satisfactory in terms of helping to maintain the body's natural defenses and keeping the body in shape.
[21]Le produit de combinaison de la présente invention aide au maintien des défenses naturelles de l'organisme en stimulant et renforçant l'immunité des individus. Il aide également l'organisme à retrouver la forme. Le produit de la présente invention est sans effet secondaire ni accoutumance. [21] The combination product of the present invention helps to maintain the body's natural defenses by stimulating and strengthening the immunity of individuals. It also helps the body to get back in shape. The product of the present invention is without side effects or addiction.
[22]Ainsi, le produit selon la présente invention permet d'augmenter la résistance contre la fatigue, notamment grâce à la présence de gelée royale, de vitamine C et de spiruline, d'augmenter la résistance de l'organisme face aux agressions extérieures, notamment grâce à la spiruline et à la souche bactérienne, et d'augmenter la résistance physique, notamment grâce à la vitamine D qui participe à la croissance osseuse. [22] Thus, the product according to the present invention makes it possible to increase resistance against fatigue, in particular thanks to the presence of royal jelly, vitamin C and spirulina, to increase the body's resistance to external aggressions. , especially thanks to spirulina and the bacterial strain, and to increase physical resistance, in particular thanks to vitamin D which participates in bone growth.
[23]Le produit selon la présente invention présente donc l'avantage d'associer une souche bactérienne, un « superaliment », des produits de la ruche et des vitamines en une seule prise. [23] The product according to the present invention therefore has the advantage of combining a bacterial strain, a “superfood”, bee products and vitamins in a single intake.
[24]Le produit de la présente invention se présente, de préférence, sous forme de fioles permettant une conservation optimale de la composition. [24] The product of the present invention is preferably in the form of vials allowing optimum preservation of the composition.
[25]RESUME DE L'INVENTION [25] SUMMARY OF THE INVENTION
[26]La présente invention se rapporte à un produit de combinaison, comprenant à titre de substances actives, au moins : [26] The present invention relates to a combination product, comprising as active substances at least:
(i) de la gelée royale, (i) royal jelly,
(ii) de la spiruline, (ii) spirulina,
(iii) de la vitamine C, (iii) vitamin C,
(iv) de la vitamine D3, (iv) vitamin D3,
(v) des vitamines du groupe B (v) group B vitamins
(vi) au moins une souche bactérienne pour aider au maintien des défenses naturelles de l'organisme et à retrouver la forme [27]De préférence, les vitamines du groupe B sont choisies parmi les vitamines du groupe B sont choisies parmi la vitamine Bl, B2 et B6 ou une association de ces vitamines. (vi) at least one bacterial strain to help maintain the body's natural defenses and get back in shape [27] Preferably, group B vitamins are chosen from group B vitamins are chosen from vitamin B1, B2 and B6 or a combination of these vitamins.
[28]De préférence, la souche bactérienne est une bactérie lactique, plus préférentiellement du genre Lactobacillus rhamnosus. [28] Preferably, the bacterial strain is a lactic acid bacterium, more preferably of the genus Lactobacillus rhamnosus.
[29]La présente invention se rapporte également à un produit de combinaison, comprenant à titre de substances actives, au moins : [29] The present invention also relates to a combination product, comprising as active substances at least:
(i) de la gelée royale, (i) royal jelly,
(ii) de la spiruline, (ii) spirulina,
(iii) de la vitamine C, (iii) vitamin C,
(iv) de la vitamine D3, (iv) vitamin D3,
(v) des vitamines du groupe B (v) group B vitamins
(vi) au moins une souche bactérienne pour son utilisation dans la prévention et/ou le traitement des pathologies infectieuses. (vi) at least one bacterial strain for its use in the prevention and / or treatment of infectious pathologies.
[30]Dans certains modes de réalisation, le produit de combinaison selon l'invention comprend, en plus de la gelée royale, de la spiruline, de la vitamine C, de la vitamine D3, des vitamines du groupe B ainsi qu'au moins une souche bactérienne, à titre de substances actives : [30] In certain embodiments, the combination product according to the invention comprises, in addition to royal jelly, spirulina, vitamin C, vitamin D3, vitamins of group B as well as at least a bacterial strain, as active substances:
Des plantes ou extraits de plantes, tels que par exemple l'astragale, le ginseng, le guarana ou l'éleuthérocoque Plants or plant extracts, such as for example astragalus, ginseng, guarana or eleutherococcus
Des vitamines et minéraux, tels que par exemple la vitamine A, la vitamine E, et/ou le zinc, le fer ou le sélénium Vitamins and minerals, such as for example vitamin A, vitamin E, and / or zinc, iron or selenium
[31]Dans certains modes de réalisation de l'invention, le produit de combinaison selon l'invention peut se présenter sous la forme d'une composition unique (ou combinée) contenant au moins à titre de substances actives : [31] In certain embodiments of the invention, the combination product according to the invention may be in the form of a single (or combined) composition containing at least as active substances:
(i) de la gelée royale, (i) royal jelly,
(ii) de la spiruline, (ii) spirulina,
(iii) de la vitamine C, (iii) vitamin C,
(iv) de la vitamine D3, (iv) vitamin D3,
(v) des vitamines du groupe B (v) group B vitamins
(vi) au moins une souche bactérienne dans un milieu physiologiquement acceptable. (vi) at least one bacterial strain in a physiologically acceptable medium.
[32]Dans certains modes de réalisation, le produit de combinaison de l'invention est caractérisé en ce que la gelée royale, la spiruline, la vitamine C, la vitamine D3, les vitamines du groupe B ainsi que la souche bactérienne sont administrés sous la forme d'une fiole comprenant (1) une partie sèche qui comprend: de 20 à 300 mg, de préférence 30 à 100 mg de vitamine C de 0,05 à 8 mg de préférence 0,2 à 6 mg de vitamine B1 de 0,05 à 8 mg de préférence 0,2 à 6 mg de vitamine B2 de 0,05 à 8 mg de préférence 0,2 à 6 mg de vitamine B6 de 0.5 à 20 pg, de préférence 1 à 10 pg de vitamine D3 de 0,5 à 5 milliards d'unités formant colonie, de préférence de 0.75 à 2 milliards d'unités formant colonie de souche bactérienne [32] In certain embodiments, the combination product of the invention is characterized in that the royal jelly, spirulina, vitamin C, vitamin D3, group B vitamins as well as the bacterial strain are administered under the shape of a flask comprising (1) a dry part which comprises: from 20 to 300 mg, preferably 30 to 100 mg of vitamin C from 0.05 to 8 mg, preferably 0.2 to 6 mg of vitamin B1 from 0.05 to 8 mg of preferably 0.2 to 6 mg of vitamin B2 from 0.05 to 8 mg preferably 0.2 to 6 mg of vitamin B6 from 0.5 to 20 pg, preferably 1 to 10 pg of vitamin D3 from 0.5 to 5 billion colony forming units, preferably 0.75 to 2 billion bacterial strain colony forming units
(2) d'autre partie liquide qui comprend : de 50 à 500 mg, de préférence de 100 à 300 mg de gelée royale de 50 à 500 mg, de préférence de 100 à 300 mg de spiruline (2) other liquid part which comprises: from 50 to 500 mg, preferably from 100 to 300 mg of royal jelly from 50 to 500 mg, preferably from 100 to 300 mg of spirulina
[33]Selon un mode de réalisation particulier de l'invention, le produit de combinaison est caractérisé en ce que les ingrédients actifs (i), (ii), (iii), (iv), (v) et (vi) sont dans milieu adapté à l'administration par voie orale. Dans le cadre de la présente invention, le produit de combinaison comprend deux formes, une sèche et une liquide, les deux formes étant mélangées juste avant ingestion. Cela permet d'améliorer la stabilité de l'ensemble des ingrédients actifs entrant dans la composition selon l'invention. [33] According to a particular embodiment of the invention, the combination product is characterized in that the active ingredients (i), (ii), (iii), (iv), (v) and (vi) are in a medium suitable for oral administration. In the context of the present invention, the combination product comprises two forms, a dry and a liquid, the two forms being mixed just before ingestion. This makes it possible to improve the stability of all the active ingredients entering into the composition according to the invention.
[34]Un exemple de fiole pouvant être utilisé dans le cadre de la présente invention est décrit dans le brevet EP 2 616 354. Le dispositif de fermeture de ce type de fiole ou récipient est adapté pour contenir un premier composant (dans le cadre de la présente invention, la partie sèche) qui, au moment de l'ouverture de la fiole, va être libérée dans la fiole qui contient la partie liquide. [34] An example of a vial that can be used in the context of the present invention is described in patent EP 2 616 354. The closure device of this type of vial or container is adapted to contain a first component (in the context of the present invention, the dry part) which, when the vial is opened, will be released into the vial which contains the liquid part.
[35]Les différents modes de réalisations de l'invention sont particulièrement décrits dans la description détaillée ci-après. Ces modes de réalisation peuvent être pris séparément ou en combinaison les uns avec les autres. [35] The various embodiments of the invention are particularly described in the detailed description below. These embodiments can be taken separately or in combination with each other.
[36]DESCRIPTION DETAILLEE DE L'INVENTION : [36] DETAILED DESCRIPTION OF THE INVENTION:
[37]Dans la présente invention, la demanderesse a mis en évidence que l'association d'au moins , (i) de la gelée royale, (ii) de la spiruline, (iii) de la vitamine C, (iv) de la vitamine D3, (v) des vitamines du groupe B, (vi) au moins une souche bactérienne, présentait un effet synergique pour aider au maintien des défenses naturelles de l'organisme et à retrouver la forme. [37] In the present invention, the Applicant has demonstrated that the combination of at least, (i) royal jelly, (ii) spirulina, (iii) vitamin C, (iv) vitamin D3, (v) group B vitamins, (vi) at least one bacterial strain, exhibited a synergistic effect to help maintain the body's natural defenses and regain shape.
[38]Par effet synergique, il est entendu selon la présente invention que l'association d'au moins (i) de la gelée royale, (ii) de la spiruline, (iii) de la vitamine C, (iv) de la vitamine D3, (v) des vitamines du groupe B, (vi) au moins une souche bactérienne, présente un effet sur l'aide au maintien des défenses naturelles de l'organisme et sur l'aide à retrouver la forme, au cours du traitement qui est supérieur aux effets cumulés d'un traitement ne comprenant pas cette association ou ne comprenant qu'une partie de cette association. [38] By synergistic effect, it is understood according to the present invention that the combination of at least (i) royal jelly, (ii) spirulina, (iii) vitamin C, (iv) vitamin D3, (v) vitamins of group B, (vi) at least one bacterial strain, has an effect on helping to maintain the body's natural defenses and on helping to regain the form, during the treatment which is superior to the cumulative effects of a treatment not comprising this association or comprising only part of this association.
[39]La gelée royale [39] Royal jelly
[40]La gelée royale est le produit de sécrétion du système glandulaire céphalique (glandes hypopharyngiennes et glandes mandibulaires) des abeilles ouvrières, entre le cinquième et le quatorzième jour de leur existence (ouvrières qui portent alors le nom de nourrices). La gelée royale contient des lipides (4,5 %), des glucides (14,5 %), des protides (13 %) et de l'eau (environ 66 %). [40] Royal jelly is the secretion product of the cephalic glandular system (hypopharyngeal glands and mandibular glands) of worker bees, between the fifth and the fourteenth day of their existence (workers who then bear the name of nurse). Royal jelly contains lipids (4.5%), carbohydrates (14.5%), proteins (13%) and water (approximately 66%).
[41]On y trouve également des vitamines (la gelée royale est le produit naturel connu le plus riche qui soit en vitamine B5), des oligo-éléments, de l'acétylcholine (jusqu'à 1 mg g— 1), des facteurs antibiotiques particulièrement actifs sur les bactéries du genre Proteus et sur Escherichia coli B. [41] It also contains vitamins (royal jelly is the richest known natural product in vitamin B5), trace elements, acetylcholine (up to 1 mg g— 1), antibiotics particularly active against bacteria of the genus Proteus and on Escherichia coli B.
[42]La gelée royale contient une proportion considérable de protéines, d'acides aminés, de lipides, de vitamines et de sucres, et est souvent considérée comme ayant diverses vertus nutritionnelles et médicinales sur les humains. Quelques expérimentations in vivo et in vitro ont permis de suggérer une activité vasodilatatrice et hypotensive, anticholestérolémique et anticancérigène. [42] Royal jelly contains a considerable proportion of protein, amino acids, lipids, vitamins and sugars, and is often considered to have various nutritional and medicinal benefits in humans. Some in vivo and in vitro experiments have made it possible to suggest vasodilator and hypotensive, anticholesterolemic and anticarcinogenic activity.
[43]La composition selon la présente invention comprend de 50 à 500 mg, de préférence de 100 à 300 mg de gelée royale. [43] The composition according to the present invention comprises from 50 to 500 mg, preferably from 100 to 300 mg of royal jelly.
[44]La spiruline [44] Spirulina
[45]La spiruline est une algue qui existe telle quelle depuis plus de 3 milliards d'années. Ainsi nommée en raison de sa forme spiralée, elle appartient à la famille des cyanobactéries ou microalgues bleu-vert. Il existe près de 1 500 espèces d'algues bleues, et 36 espèces de spiruline sont comestibles. La principale espèce actuellement offerte sur le marché est la Spirulina platensis. D'abord cultivée principalement en Californie et à Hawaï, la spiruline est maintenant produite de façon contrôlée partout dans le monde où le climat le permet : Chili, Chine, Cuba, Inde, Afrique de l'Ouest, Grèce (en serres géothermiques), etc. Dans le commerce, la spiruline se présente généralement sous la forme d'une poudre bleu-vert déshydratée, en vrac ou en capsules. [45] Spirulina is an algae that has existed as it is for more than 3 billion years. So named because of its spiral shape, it belongs to the family of cyanobacteria or blue-green microalgae. There are nearly 1,500 species of blue algae, and 36 species of spirulina are edible. The main species currently available on the market is Spirulina platensis. First cultivated mainly in California and Hawaii, spirulina is now produced in a controlled manner all over the world where the climate allows it: Chile, China, Cuba, India, West Africa, Greece (in geothermal greenhouses), etc. In the market, spirulina is generally in the form of a dehydrated blue-green powder, in bulk or in capsules.
[46]La spiruline, faible en calories, contient une mine de nutriments dans un très petit volume. Sa teneur peut cependant varier selon son origine géographique, mais aussi selon les procédés de culture, de séchage et de broyage. [47]La spiruline contient de 55 % à 70 % de protéines d'excellente qualité (proportion des acides aminés et digestibilité optimales), soit de 2,5 g à 3,5 g de protéines par 5 g de poudre. [46] Spirulina, low in calories, contains a wealth of nutrients in a very small volume. Its content can however vary according to its geographical origin, but also according to the cultivation, drying and grinding processes. [47] Spirulina contains 55% to 70% protein of excellent quality (proportion of amino acids and optimal digestibility), or 2.5 g to 3.5 g of protein per 5 g of powder.
[48]La spiruline est une source exceptionnelle de caroténoïdes variés (bêta-carotène principalement, mais aussi cryptoxanthine, lutéine, zéaxanthine, etc.), soit autour de 22 mg/5 g. Elle fournit notamment une quantité astronomique de bêta-carotène, soit de 12000 III à 25 000 III par 5 g de poudre. [48] Spirulina is an exceptional source of various carotenoids (mainly beta-carotene, but also cryptoxanthin, lutein, zeaxanthin, etc.), ie around 22 mg / 5 g. In particular, it provides an astronomical amount of beta-carotene, ie from 12,000 III to 25,000 III per 5 g of powder.
[49] Elle constitue une excellente source de fer, soit de 3 mg à 8 mg par 5 g. [49] It is an excellent source of iron, from 3 mg to 8 mg per 5 g.
[50] Elle contient une quantité appréciable d'acide gamma-linolénique (de 40 mg à 50 mg/5 g), un acide gras insaturé de la famille des oméga-6. [50] It contains a significant amount of gamma-linolenic acid (40 mg to 50 mg / 5 g), an unsaturated fatty acid from the omega-6 family.
[51]De plus, la spiruline est riche en phycocyanine, le seul pigment bleu naturel pouvant servir de colorant alimentaire et auquel on attribue une activité antioxydante importante. Elle contient également de la chlorophylle et de petites quantités de plusieurs minéraux. [51] In addition, spirulina is rich in phycocyanin, the only natural blue pigment that can serve as a food coloring and which is attributed a significant antioxidant activity. It also contains chlorophyll and small amounts of several minerals.
[52]Voilà pourquoi on parle souvent de cette algue comme d'un « superaliment ». [52] This is why we often speak of this alga as a "superfood".
[53]La composition selon la présente invention comprend de 50 à 500 mg, de préférence de 100 à 300 mg de spiruline. Ses quantités de spiruline représentent en équivalent plante de 500 à 5000 mg, de préférence 1000 à 3000 mg. [53] The composition according to the present invention comprises from 50 to 500 mg, preferably from 100 to 300 mg of spirulina. Its quantities of spirulina represent in plant equivalent from 500 to 5000 mg, preferably 1000 to 3000 mg.
[54]La vitamine C [54] Vitamin C
[55]La vitamine C est une vitamine hydrosoluble sensible à la chaleur et à la lumière jouant un rôle important dans le métabolisme de l'être humain et de nombreux autres mammifères. Chimiquement parlant, il s'agit de l'acide L-ascorbique, un des stéréoisomères de l'acide ascorbique, et de ses sels, les ascorbates. Les plus courants sont l'ascorbate de sodium et l'ascorbate de calcium. [55] Vitamin C is a water soluble, heat and light sensitive vitamin that plays an important role in the metabolism of humans and many other mammals. Chemically speaking, it is L-ascorbic acid, one of the stereoisomers of ascorbic acid, and its salts, the ascorbates. The most common are sodium ascorbate and calcium ascorbate.
[56]La vitamine C est un cofacteur enzymatique impliqué dans un certain nombre de réactions physiologiques (hydroxylation). Elle est requise dans la synthèse du collagène et des globules rouges et contribue au système immunitaire. Elle joue également un rôle dans le métabolisme du fer en tant que promoteur de son absorption; son utilisation est donc déconseillée chez les patients porteurs d'une surcharge en fer et particulièrement d'une hémochromatose. Sous forme oxydée (acide déshydroascorbique), elle traverse la barrière hémato-encéphalique pour accéder au cerveau et à plusieurs organes à forte concentration en vitamine C. [56] Vitamin C is an enzymatic cofactor involved in a number of physiological reactions (hydroxylation). It is required in the synthesis of collagen and red blood cells and contributes to the immune system. It also plays a role in the metabolism of iron as a promoter of its absorption; its use is therefore not recommended in patients with an iron overload and particularly hemochromatosis. In oxidized form (dehydroascorbic acid), it crosses the blood-brain barrier to access the brain and several organs with a high concentration of vitamin C.
[57]Cette vitamine est largement utilisée en automédication dans le rhume banal. Elle semble raccourcir la durée des symptômes et les améliorer, chez l'adulte. [58]La composition selon la présente invention comprend de 20 à 300 mg, de préférence 30 à 100 mg de vitamine C. [57] This vitamin is widely used as a self-medication for the common cold. It seems to shorten the duration of symptoms and improve them in adults. [58] The composition according to the present invention comprises 20 to 300 mg, preferably 30 to 100 mg of vitamin C.
[59]La vitamine B1 [59] Vitamin B1
[60]La thiamine ou vitamine B1 (ou encore aneurine) est un précurseur métabolique de la thiamine pyrophosphate (TPP), une coenzyme essentielle à certaines décarboxylases. Chez les animaux, la thiamine est une vitamine hydrosoluble de la famille des vitamines B qu'ils doivent trouver dans leur alimentation. Elle est en revanche synthétisée par les bactéries, les plantes et les champignons. Elle est indispensable à la transformation des glucides en énergie par le cycle de Krebs et est nécessaire au bon fonctionnement du système nerveux et des muscles. Elle est en effet indispensable à la transformation du pyruvate produit par la glycolyse et toxique pour le système nerveux. [60] Thiamine or vitamin B1 (or aneurine) is a metabolic precursor of thiamine pyrophosphate (TPP), a coenzyme essential for certain decarboxylases. In animals, thiamine is a water-soluble vitamin from the family of B vitamins that they must find in their diet. On the other hand, it is synthesized by bacteria, plants and fungi. It is essential for the transformation of carbohydrates into energy by the Krebs cycle and is necessary for the proper functioning of the nervous system and muscles. It is in fact essential for the transformation of pyruvate produced by glycolysis and toxic for the nervous system.
[61]Chez l'homme, une carence alimentaire en vitamine B1 cause le béribéri et peut aussi causer une encéphalopathie de Gayet-Wernicke. [61] In humans, a dietary vitamin B1 deficiency causes beriberi and can also cause Gayet-Wernicke encephalopathy.
[62]Chez l'homme, les besoins estimés sont de 1,3 mg à 1,5 mg par jour. Chez l'adulte en bonne santé, l'absorption digestive est de 4,5 % de la dose ingérée, et baisse à 1,5 % en cas d'alcoolo-dépendance. [62] In humans, the estimated requirements are 1.3 mg to 1.5 mg per day. In healthy adults, digestive absorption is 4.5% of the ingested dose, and drops to 1.5% in cases of alcohol dependence.
[63] La composition selon la présente invention de 0,05 à 8 mg de préférence 0,2 à 6 mg de vitamine Bl. [63] The composition according to the present invention from 0.05 to 8 mg, preferably 0.2 to 6 mg of vitamin B1.
[64] La vitamine B2 [64] Vitamin B2
[65]La vitamine B2, correspondant à la riboflavine, ou lactoflavine, est une vitamine hydrosoluble nécessaire à la synthèse de la flavine adénine dinucléotide (FAD) et de la flavine mononucléotide (FMN), deux cofacteurs essentiels aux flavoprotéines. [65] Vitamin B2, corresponding to riboflavin, or lactoflavin, is a water-soluble vitamin required for the synthesis of flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN), two essential cofactors of flavoproteins.
[66]La vitamine B2 joue un rôle important dans la transformation des aliments simples (glucides, lipides et protéines) en énergie. Elle intervient dans le métabolisme de réparation des muscles. [66] Vitamin B2 plays an important role in converting simple foods (carbohydrates, fats and proteins) into energy. It is involved in the repair metabolism of muscles.
[67]La riboflavine se trouve naturellement dans les asperges, le maïs soufflé, les bananes, les kakis, le gombo, les blettes à carde, le fromage, le lait, le yaourt, la viande, les œufs, le poisson et les haricots verts, dont chacun contient au moins 0,1 mg de vitamine B par 85-300g. D'autres sources sont les légumes verts feuillus, le foie, les reins, les légumineuses, les tomates, les levures, les champignons et les amandes. [67] Riboflavin is found naturally in asparagus, popcorn, bananas, persimmons, okra, Swiss chard, cheese, milk, yogurt, meat, eggs, fish and beans. greens, each of which contains at least 0.1 mg of vitamin B per 85-300g. Other sources are green leafy vegetables, liver, kidneys, legumes, tomatoes, yeasts, mushrooms and almonds.
[68] Elle est également utilisée en tant que traitement de fond de la migraine. [68] It is also used as a disease-modifying treatment for migraine.
[69]La composition selon la présente invention comprend de 0,05 à 8 mg de préférence 0,2 à 6 mg de vitamine B2. [69] The composition according to the present invention comprises from 0.05 to 8 mg, preferably 0.2 to 6 mg of vitamin B2.
[70]La vitamine B6 [71]La vitamine B6 est une vitamine hydrosoluble existant sous plusieurs formes, le phosphate de pyridoxal étant sa forme biologiquement active, en tant que cofacteur intervenant dans plusieurs réactions du métabolisme des acides aminés, notamment des transaminations, désaminations et décarboxylations. Le phosphate de pyridoxal intervient également dans la réaction d'hydrolyse du glycogène en glucose. [70] Vitamin B6 [71] Vitamin B6 is a water-soluble vitamin that exists in several forms, pyridoxal phosphate being its biologically active form, as a cofactor involved in several reactions of amino acid metabolism, including transaminations, deaminations and decarboxylations. Pyridoxal phosphate is also involved in the reaction of hydrolysis of glycogen to glucose.
[72]La vitamine B6 est connue sous sept formes différentes, interconvertibles entre elles hormis la dernière : [72] Vitamin B6 is known in seven different forms, interconvertible between them except the last one:
1. pyridoxine (PN), forme sous laquelle la vitamine B6 est administrée en complément alimentaire, 1.pyridoxine (PN), the form in which vitamin B6 is administered as a food supplement,
2. phosphate de pyridoxine (PNP), 2.pyridoxine phosphate (PNP),
3. pyridoxal (PL), 3.pyridoxal (PL),
4. phosphate de pyridoxal (PLP), forme biologiquement active (distribuée comme supplément vitaminique « P-5-P »), 4.pyridoxal phosphate (PLP), biologically active form (distributed as vitamin supplement "P-5-P"),
5. pyridoxamine (PM), 5.pyridoxamine (PM),
6. phosphate de pyridoxamine (PMP), 6.pyridoxamine phosphate (PMP),
7. acide 4-pyridoxique (PA), catabolite excrété par voie urinaire. 7. 4-pyridoxic acid (PA), a catabolite excreted in the urine.
[73]La vitamine B6 participe à la transformation du tryptophane en vitamine B3, et au métabolisme des lipides et des acides aminés (décarboxylation et transamination). Le phosphate de pyridoxal permet la conversion du glycogène en glucose (Glucose-1- Phospate) par la Glycogène phosphorylase. [73] Vitamin B6 participates in the transformation of tryptophan into vitamin B3, and in the metabolism of lipids and amino acids (decarboxylation and transamination). Pyridoxal phosphate allows the conversion of glycogen into glucose (Glucose-1-Phospate) by Glycogen phosphorylase.
[74]La vitamine B6 participe également à la biosynthèse de la sérotonine. [74] Vitamin B6 also participates in the biosynthesis of serotonin.
[75] Elle est présente en quantités importantes dans les volailles, les foies (bœuf, agneau, veau), les bananes, les différentes formes de choux, les tomates, les épinards, les pommes de terre... [75] It is present in large quantities in poultry, livers (beef, lamb, veal), bananas, various forms of cabbage, tomatoes, spinach, potatoes ...
[76]Associée à la cystine, elle est administrée pour faciliter le développement des phanères (cheveux, ongles...). [76] Associated with cystine, it is administered to facilitate the development of integuments (hair, nails, etc.).
[77] La composition selon la présente invention comprend de 0,05 à 8 mg de préférence 0,2 à 6 mg de vitamine B6. [77] The composition according to the present invention comprises from 0.05 to 8 mg, preferably 0.2 to 6 mg of vitamin B6.
[78]La vitamine D3 [78] Vitamin D3
[79]Le cholécalciférol est une forme de vitamine D, également appelée vitamine D3. La vitamine D3 est un sécostéroïde plutôt parent de la testostérone, du cholestérol et du cortisol. [79] Cholecalciferol is a form of vitamin D, also called vitamin D3. Vitamin D3 is a secosteroid rather related to testosterone, cholesterol and cortisol.
[80]La vitamine D possède une double origine : elle est apportée par l'alimentation et synthétisée par l'organisme au niveau de la peau sous l'action des rayons UVB du soleil. [81]Les sujets s'exposant très peu au soleil peuvent présenter des carences plus ou moins importantes en vitamine D. Les personnes à peau claire synthétisent la vitamine D plus vite que celles à peau foncée, et ont donc besoin d'une durée d'exposition moins longue pour transformer les précurseurs de la vitamine D produits par le foie en vitamine D. La quantité de vitamine D que la peau peut produire est limitée ; une exposition prolongée à la lumière solaire (plus de 30 minutes pour une personne à peau claire, jusqu'à trois heures pour les personnes à peau sombre) n'augmente pas la quantité de cholécalciférol produite par l'organisme. Pour une personne à peau claire, une exposition de 10 à 15 minutes quelques fois par semaine suffit à couvrir les besoins en vitamine D3. La vitamine D fabriquée par la peau est mise en réserve au niveau du foie, du muscle et du tissu gras et utilisée à la demande au cours des périodes hivernales. [80] Vitamin D has a dual origin: it is provided by food and synthesized by the body in the skin under the action of UVB rays from the sun. [81] People with very little exposure to the sun may have varying degrees of vitamin D deficiency. People with fair skin synthesize vitamin D faster than those with dark skin, and therefore need a long period of time. shorter exposure to convert vitamin D precursors produced by the liver into vitamin D. The amount of vitamin D that the skin can produce is limited; prolonged exposure to sunlight (more than 30 minutes for a fair-skinned person, up to three hours for a dark-skinned person) does not increase the amount of cholecalciferol produced by the body. For a person with fair skin, an exposure of 10 to 15 minutes a few times a week is enough to cover the needs in vitamin D3. Vitamin D produced by the skin is stored in the liver, muscle and fatty tissue and used on demand during winter periods.
[82]Deux formes de vitamine D existent : la vitamine D2 ou ergocalciférol produite par les végétaux et la vitamine D3 ou cholécalciférol produite par les animaux, ainsi que par certains lichens. Chez l'homme, ces deux formes sont converties en 1,25- dihydroxyvitamine D (communément appelé vitamine D), leur principal métabolite actif. [82] Two forms of vitamin D exist: vitamin D2 or ergocalciferol produced by plants and vitamin D3 or cholecalciferol produced by animals, as well as by certain lichens. In humans, these two forms are converted to 1,25-dihydroxyvitamin D (commonly known as vitamin D), their main active metabolite.
[83] La fonction essentielle de la vitamine D est d'augmenter la capacité d'absorption de l'intestin pour le calcium et le phosphore ce qui permet : [83] The essential function of vitamin D is to increase the absorption capacity of the intestine for calcium and phosphorus which allows:
1. d'assurer une minéralisation optimale des tissus minéralisés, notamment os, cartilage et dents ; 1. ensure optimal mineralization of mineralized tissues, in particular bone, cartilage and teeth;
2. de contribuer au maintien des concentrations plasmatiques du calcium et du phosphore. 2. contribute to the maintenance of plasma concentrations of calcium and phosphorus.
[84]Les signes cliniques de carence en vitamine D sont : l'ostéomalacie et le rachitisme au niveau osseux, la baisse de tonus musculaire, les crises de tétanie et les convulsions (en relation avec une hypocalcémie) et parfois l'anémie. Chez les personnes âgées, la carence en vitamine D constitue un terrain favorable à la perte osseuse (donc à l'ostéoporose), et à la dépression (comme l'a confirmé une étude néerlandaise évoquée dans Archives of General Psychiatry (mai 2008)). [84] The clinical signs of vitamin D deficiency are: osteomalacia and rickets in the bone, decreased muscle tone, tetany attacks and convulsions (related to hypocalcemia) and sometimes anemia. In the elderly, vitamin D deficiency constitutes a favorable ground for bone loss (therefore osteoporosis), and depression (as confirmed by a Dutch study mentioned in Archives of General Psychiatry (May 2008)) .
[85]Plusieurs tranches d'âge constituent des populations à risque de carence en vitamine D : ce sont les nouveau-nés, les nourrissons, les femmes enceintes et les personnes âgées, particulièrement celles placées en institution, qui s'exposent peu au soleil et/ou ont des besoins accrus. D'autres facteurs peuvent aggraver ces risques de carence, la forte pigmentation cutanée, les régimes alimentaires spécifiques (végétarien, macrobiotique), les pathologies induisant une malabsorption intestinale. [85] Several age groups constitute populations at risk of vitamin D deficiency: they are newborns, infants, pregnant women and the elderly, particularly those placed in institutions, who are not exposed to the sun much. and / or have increased needs. Other factors may worsen these risks of deficiency, the strong skin pigmentation, specific diets (vegetarian, macrobiotic), pathologies inducing intestinal malabsorption.
[86]Les apports nutritionnels conseillés en vitamine D ont été définis en considérant que la production endogène couvre 50 à 70 % des besoins quotidiens en cette vitamine. [87]Un nombre limité d'aliments contient des quantités significatives de vitamine D. En effet, ces teneurs sont étroitement liées à la présence de matières grasses dans les aliments. Les meilleures sources de vitamine D sont les poissons de mer gras, quel que soit leur mode de préparation et de conservation (cuisson à l'eau, fumage, appertisation, grillade) : harengs, saumons, sardines, maquereaux par exemple. Le jaune d'œuf, les produits laitiers, le soja et ses dérivés (tofu et lait de soja par exemple) et certains champignons (avec de grandes différences selon les variétés) sont aussi des sources de vitamine D. De faibles quantités de vitamine D sont également apportées par les viandes, les abats et les pâtés. Les poissons maigres (raie, sole, colin...) en sont dépourvus. Certains lichens produisent également du cholécalciférol (vitamine D3), et sont utilisés pour produire des compléments alimentaires végétaux en cette vitamine. [86] The recommended nutritional intake of vitamin D was defined considering that endogenous production covers 50 to 70% of the daily requirements of this vitamin. [87] A limited number of foods contain significant amounts of vitamin D. Indeed, these levels are closely linked to the presence of fat in foods. The best sources of vitamin D are fatty sea fish, whatever their method of preparation and conservation (boiling, smoking, canning, grilling): herring, salmon, sardines, mackerel for example. Egg yolks, dairy products, soy and its derivatives (tofu and soy milk for example) and certain mushrooms (with great differences depending on the variety) are also sources of vitamin D. Low amounts of vitamin D are also provided by meats, offal and pâtés. Lean fish (ray, sole, hake ...) do not have them. Some lichens also produce cholecalciferol (vitamin D3), and are used to produce plant food supplements with this vitamin.
[88]La composition selon la présente invention comprend de 0.5 à 20 pg, de préférence 1 à 10 pg de vitamine D3. [88] The composition according to the present invention comprises from 0.5 to 20 pg, preferably 1 to 10 pg of vitamin D3.
[89] La souche bactérienne ou probiotique [89] The bacterial or probiotic strain
[90]lnitialement, les probiotiques sont des micro-organismes vivants (bactéries ou levures) qui, ajoutés comme compléments à certains produits alimentaires comme les yaourts ou les céréales, et ingérés en quantité adéquate, sont censés conférer un bénéfice en matière de santé à l'hôte sain. [90] Initially, probiotics are living microorganisms (bacteria or yeasts) which, added as a supplement to certain food products such as yogurt or cereals, and ingested in adequate quantities, are believed to confer a health benefit on the body. the healthy host.
[91]En 2001, l'Organisation mondiale de la Santé (OMS) et l'Organisation des Nations unies pour l'alimentation et l'agriculture (FAO) ont donné une définition officielle des probiotiques qui sont des « micro-organismes vivants qui, lorsqu'ils sont ingérés en quantité suffisante, exercent des effets positifs sur la santé, au-delà des effets nutritionnels traditionnels ». [91] In 2001, the World Health Organization (WHO) and the Food and Agriculture Organization of the United Nations (FAO) gave an official definition of probiotics which are "living microorganisms that , when ingested in sufficient quantity, exert positive effects on health, beyond the traditional nutritional effects ”.
[92] [92]
[93]Le microbiote intestinal humain (terme privilégié à celui de microflore) comprend de 800 à 1 000 espèces microbiennes connuesl5 et sa diversité en espèces dominantes est propre à chacun. Au plan quantitatif, il se montre très stable dans le temps (pour un individu donné sur 2 mois à 2 ans), bien qu'il ne soit pas possible de définir un microbiote intestinal de l'espèce humaine par le profil d'espèces dominantes. C'est un consortium adapté à l'hôte, stable, c'est-à-dire résistant à la modification. [93] The human gut microbiota (preferred term to that of microflora) comprises 800 to 1000 known microbial species15 and its diversity in dominant species is unique to each. Quantitatively, it is very stable over time (for a given individual over 2 months to 2 years), although it is not possible to define an intestinal microbiota of the human species by the profile of dominant species. . It is a consortium adapted to the host, stable, that is to say resistant to modification.
[94]Parmi les microorganismes utilisés les bactéries lactiques sont les plus utilisés. Ce sont des hôtes naturels du microbiote intestinal humain. [94] Among the microorganisms used, lactic acid bacteria are the most widely used. They are natural hosts for the human gut microbiota.
[95]Les probiotiques les plus étudiés appartiennent à deux genres : [95] The most studied probiotics belong to two genera:
1. Bifidobacterium spp. plus particulièrement les espèces Bifidobacterium bifidum (bifidus), Bifidobacterium lactis, Bifidobacterium longum, Bifidobacterium breve... 2. Lactobacillus spp. plus particulièrement Lactobacillus reuteri, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus plantarum, Lactobacillus rhamnosus... 1. Bifidobacterium spp. more particularly the species Bifidobacterium bifidum (bifidus), Bifidobacterium lactis, Bifidobacterium longum, Bifidobacterium breve ... 2. Lactobacillus spp. more particularly Lactobacillus reuteri, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus plantarum, Lactobacillus rhamnosus ...
[96]Les études les plus récentes montrent que selon la souche et l'espèce animale testée, les effets diffèrent. Ils peuvent diminuer la durée d'une diarrhée infectieuse aiguë ou d'une diarrhée persistante chez l'enfant. Les probiotiques tendent à réduire l'inflammation intestinale. [96] The most recent studies show that depending on the strain and the animal species tested, the effects differ. They can decrease the duration of acute infectious diarrhea or persistent diarrhea in children. Probiotics tend to reduce inflammation in the gut.
[97] Ils ont montré un intérêt dans nombre de pathologies intestinales d'origine infectieuse ou inflammatoire : gastro-entérite; ulcère gastro-duodénal; maladie de Crohn; pour le diabète de type 2 et l'obésité, on observe également des flores intestinales spécifiques ; santé du nourrisson (en améliorant préventivement le système immunitaire, qui bloque ainsi mieux certaines septicémies néonatales). [97] They showed an interest in a number of intestinal pathologies of infectious or inflammatory origin: gastroenteritis; peptic ulcer; Crohn's disease; for type 2 diabetes and obesity, specific intestinal flora are also observed; infant health (by preventively improving the immune system, which thus better blocks certain neonatal sepsis).
[98]Les mécanismes d'action des probiotiques reposent sur un effet de symbiose en permettant au microbiote intestinal de conserver une dominante majoritairement non- pathogène. Ils moduleraient l'activité du système immunitaire intestinal, en renforçant l'immunité générale quand elle est faible, par exemple chez l'enfant, immature (chez le nouveau-né) ou la personne âgée. À contrario ils pourraient diminuer la sur-activation du système immunitaire, en cas d'allergies ou de maladies inflammatoires de l'intestin, donc en améliorant la fonction de barrière de la muqueuse intestinale par augmentation de la production et qualité du mucus et/ou des anticorps de type IgA. Ils ont un effet anti-pathogènes direct (par compétition) en limitant l'adhésion des pathogènes aux parois intestinales. [98] The mechanisms of action of probiotics are based on a symbiosis effect by allowing the intestinal microbiota to retain a predominantly non-pathogenic dominance. They modulate the activity of the intestinal immune system, strengthening general immunity when it is weak, for example in children, immature (newborns) or the elderly. Conversely, they could decrease the over-activation of the immune system, in the event of allergies or inflammatory bowel diseases, thus improving the barrier function of the intestinal mucosa by increasing the production and quality of mucus and / or IgA-type antibodies. They have a direct anti-pathogenic effect (by competition) by limiting the adhesion of pathogens to the intestinal walls.
[99]De préférence, la souche bactérienne est une bactérie lactique, plus préférentiellement du genre Lactobacillus rhamnosus. [99] Preferably, the bacterial strain is a lactic acid bacterium, more preferably of the genus Lactobacillus rhamnosus.
[100]Dans le cadre de la présente invention on préférera la souche Lactobacillus Rhamnosus (ATCC n. 53103). [100] In the context of the present invention, the Lactobacillus Rhamnosus strain (ATCC n. 53103) will be preferred.
[101]La composition selon la présente invention comprend de 0,5 à 5 milliards d'unités formant colonie, de préférence de 0.75 à 2 milliards d'unités formant colonie de souche bactérienne. Milieu physiologiquement acceptable [101] The composition according to the present invention comprises from 0.5 to 5 billion colony-forming units, preferably from 0.75 to 2 billion colony-forming units of a bacterial strain. Physiologically acceptable medium
[102]Un milieu physiologiquement acceptable est un milieu n'ayant aucun effet toxique ou préjudiciable dans les conditions d'utilisation et inerte vis-à-vis des ingrédients actifs du produit de combinaison. Un tel milieu peut par exemple comprendre différents adjuvants selon sa finalité thérapeutique ou cosmétique, comme de façon non limitative, des arômes, des colorants, des charges, des diluants, des agents mouillants ou de suspension, etc. De tels milieux peuvent également permettre une libération immédiate, modifiée ou retardée de l'un ou l'autre des ingrédients actifs. [103]Le milieu physiologiquement acceptable peut être composé de texturants, colorants, arômes, du sucre ou des sucres. [102] A physiologically acceptable medium is a medium having no toxic or detrimental effect under the conditions of use and inert with respect to the active ingredients of the combination product. Such a medium can, for example, comprise different adjuvants according to its therapeutic or cosmetic purpose, such as, without limitation, flavors, colorants, fillers, diluents, wetting or suspending agents, etc. Such media can also allow immediate, modified or delayed release of one or other of the active ingredients. [103] The physiologically acceptable medium can be composed of texturizers, colorants, flavors, sugar or sugars.
[104]Par « texturants », on entend les composés qui modifient la texture des produits dans lesquels ils sont incorporés. Des exemples de texturants sont : les farines de guar et de caroube ; les gommes arabiques, de xanthane et de gellane ; les carraghénanes ; les amidons (natifs ou modifiés) ; la cellulose microcristalline ; la gélatine ; la pectine ; les alginates (E400 à E405) ; l'agar-agar ; et leurs mélanges. Par « colorants », on entend des composés d'origine naturelle ou synthétique susceptibles de conférer à eux seuls une coloration à la composition. Des exemples de colorants alimentaires sont connus en Europe sous les codes E100 à E180. Dans le cadre de la présente invention, seule la partie liquide contient un colorant. De préférence ce colorant est un colorant caramel. [104] The term “texturizers” is understood to mean the compounds which modify the texture of the products in which they are incorporated. Examples of texturizers are: guar and carob flour; gum arabic, xanthan and gellan; carrageenans; starches (native or modified); microcrystalline cellulose; gelatin; pectin; alginates (E400 to E405); agar-agar; and their mixtures. The term “dyes” is understood to mean compounds of natural or synthetic origin capable of conferring on themselves a coloring on the composition. Examples of food colors are known in Europe under the codes E100 to E180. In the context of the present invention, only the liquid part contains a dye. Preferably this colorant is a caramel colorant.
[105]Par « arômes », on entend des composés d'origine naturelle ou synthétique susceptibles à eux seuls de modifier le goût de la composition. Des exemples d'arômes sont l'abricot, l'ananas, la banane, le cassis, la cerise, le citron, le lime, la fraise, la framboise, les fruits de la passion, la mandarine, la menthe, l'orange, la pistache, la poire, le réglisse, la rose, l'anis, la myrtille, la cannelle, le gingembre, le pamplemousse, la pomme, le kiwi, le lychee, le melon, la noix de coco, la pêche, la groseille, la goyave, la grenadine, la mangue, la mûre, la papaye, la vanilline, l'extrait naturel de vanille, les huiles essentielles et leurs mélanges. Dans le cadre de la présente invention, seule la partie liquide contient un arôme. De préférence cet arôme est un arôme pêche blanche. [105] The term “aromas” is understood to mean compounds of natural or synthetic origin which are capable on their own of modifying the taste of the composition. Examples of flavors are apricot, pineapple, banana, black currant, cherry, lemon, lime, strawberry, raspberry, passion fruit, tangerine, mint, orange , pistachio, pear, licorice, rose, anise, blueberry, cinnamon, ginger, grapefruit, apple, kiwi, lychee, melon, coconut, peach, currant, guava, grenadine, mango, blackberry, papaya, vanillin, natural vanilla extract, essential oils and mixtures thereof. In the context of the present invention, only the liquid part contains an aroma. Preferably, this aroma is a white peach aroma.
[106]Par sucre ou sucres, on entend, au sens de la présente invention, tout hydrate de carbone édulcorant ou tout édulcorant, de préférence du sirop de glucose, du saccharose, glucose, fructose, sucre inverti, miel, maltose, ou leurs mélanges. Dans le cadre de la présente invention, les sucres utilisés sont le fructose, le miel et le sucralose. [106] For the purposes of the present invention, the term “sugar or sugars” is understood to mean any sweetening carbohydrate or any sweetening agent, preferably glucose syrup, sucrose, glucose, fructose, invert sugar, honey, maltose, or theirs. mixtures. In the context of the present invention, the sugars used are fructose, honey and sucralose.
[107] La composition selon la présente invention contient également des conservateurs. [107] The composition according to the present invention also contains preservatives.
[108]Dans le cadre de la présente invention, le produit de combinaison se présente sous la forme d'une fiole associant une forme liquide et une forme sèche. On entend par forme sèche au sens de la présente invention, une forme exempte de liquide, présentant un taux d'humidité résiduelle, lorsqu'il est mesuré par la méthode de la perte à la dessiccation, inférieure à 20%, de préférence inférieure à 10%, plus préférentiellement inférieur à 5%. On entend par forme liquide au sens de la présente invention, un sirop, une émulsion, ou une solution. [108] In the context of the present invention, the combination product is in the form of a vial combining a liquid form and a dry form. For the purposes of the present invention, the term “dry form” is understood to mean a form free from liquid, exhibiting a residual moisture level, when it is measured by the loss on drying method, of less than 20%, preferably less than 10%, more preferably less than 5%. For the purposes of the present invention, the term “liquid form” means a syrup, an emulsion or a solution.
[109] Actif(s) additionnel(s) [109] Additional asset (s)
[110]Tout actif additionnel présentant un intérêt nutritionnel et/ou aidant au maintien des défenses naturelles de l'organisme peut également être ajouté aux produits de combinaison de l'invention sous forme pharmaceutique ou cosmétique. Le produit de combinaison pourra comprendre, à titre d'exemple, des vitamines, des sels minéraux, des acides aminés essentiels, des acides gras essentiels, des oligoéléments, divers extraits végétaux, des fibres, des antioxydants, des flavonoïdes. [110] Any additional active having a nutritional interest and / or helping to maintain the natural defenses of the organism can also be added to the products of combination of the invention in pharmaceutical or cosmetic form. The combination product may comprise, by way of example, vitamins, mineral salts, essential amino acids, essential fatty acids, trace elements, various plant extracts, fibers, antioxidants, flavonoids.
[111]Avantageusement, un tel actif additionnel peut être destiné à renforcer l'effet souhaité tel que décrit précédemment. [111] Advantageously, such an additional active agent can be intended to enhance the desired effect as described above.
[112]Bien entendu, l'homme du métier veillera à choisir les actifs additionnels ainsi que leur quantité de telle manière que les propriétés avantageuses de la composition conforme à l'invention ne soient pas, ou substantiellement pas, altérées par l'adjonction envisagée. [112] Of course, a person skilled in the art will take care to choose the additional active agents as well as their quantity in such a way that the advantageous properties of the composition in accordance with the invention are not, or substantially not, altered by the addition envisaged. .
[113] A titre d'actif additionnel utilisable, on peut citer : [113] As additional usable assets, we can cite:
- les vitamines hydrosolubles et les vitamines liposolubles. Des exemples de vitamines hydrosolubles présentes dans le produit sirupeux préparé selon l'invention sont notamment : la vitamine B3 (acide nicotinique) appelée également vitamine PP (Pellagra Préventive), la vitamine B5 (acide pantothénique), la vitamine B8 ou H (biotine), la vitamine B9 (acide folique) et la vitamine B12 (cobalamine). Des exemples de vitamines liposolubles présentes dans le produit sirupeux préparé selon l'invention sont notamment : la vitamine A (rétinol), la vitamine E (mélange de tocophérols et de tocotriénols) et la vitamine K (phylloquinone). - water-soluble vitamins and fat-soluble vitamins. Examples of water-soluble vitamins present in the syrupy product prepared according to the invention are in particular: vitamin B3 (nicotinic acid) also called vitamin PP (Pellagra Preventive), vitamin B5 (pantothenic acid), vitamin B8 or H (biotin) , vitamin B9 (folic acid) and vitamin B12 (cobalamin). Examples of fat-soluble vitamins present in the syrupy product prepared according to the invention are in particular: vitamin A (retinol), vitamin E (mixture of tocopherols and tocotrienols) and vitamin K (phylloquinone).
- les antioxydants, tels que les curcuminoïdes ; les caroténoïdes, notamment choisis parmi le beta.-carotène, l'astaxanthine, la zéaxanthine, la lutéine ou les composés en contenant comme les baies de goji ; des composés polyphénols, les flavonoïdes tels que les catéchines ; les proanthocyanidines, les anthocyanines, les OPC (oligomères procyanidoliques) ; les ubiquinones ; les extraits de café contenant des polyphénols et/ou des diterpènes ; les extraits de chicorés ; les extraits de ginkgo biloba ; les extraits de raisins riches en proanthocyanidines; les extraits de piment ; les extraits de soja ; le cacao ; la grenade ; l'Emblica ; le CoenzymeQlO ; le sélénium, - antioxidants, such as curcuminoids; carotenoids, especially chosen from beta.-carotene, astaxanthin, zeaxanthin, lutein or compounds containing them, such as goji berries; polyphenol compounds, flavonoids such as catechins; proanthocyanidins, anthocyanins, OPCs (procyanidol oligomers); ubiquinones; coffee extracts containing polyphenols and / or diterpenes; chicory extracts; extracts of ginkgo biloba; grape extracts rich in proanthocyanidins; chilli extracts; soy extracts; Cocoa ; the grenade ; the Emblica; CoenzymeQ10; selenium,
- les minéraux, tels que le zinc, le calcium, le cuivre, le fer, l'iode, le manganèse, le sélénium, le chrome (III), - minerals, such as zinc, calcium, copper, iron, iodine, manganese, selenium, chromium (III),
- les acides aminés, notamment les acides aminés soufrés, tels que des précurseurs de glutathion, les acides aminés du sélénium, la citrulline, - amino acids, in particular sulfur-containing amino acids, such as precursors of glutathione, amino acids of selenium, citrulline,
-les phytostérols, le resvératrol, l'hespéridine, la néohesperidine, l'acide orthosilicique, le monométhylsilanetriol, et leurs mélanges. - phytosterols, resveratrol, hesperidin, neohesperidin, orthosilicic acid, monomethylsilanetriol, and mixtures thereof.
[114]De façon préférée, un produit de combinaison selon l'invention est administré par voie orale. [115]De préférence, le produit de combinaison selon l'invention se présente sous forme d'une fiole comprenant deux parties, une partie contenant la forme liquide et le dispositif de fermeture de ce type de fiole est adapté pour contenir la partie sèche qui, au moment de l'ouverture de la fiole, va être libérée dans la fiole qui contient la partie liquide. [114] Preferably, a combination product according to the invention is administered orally. [115] Preferably, the combination product according to the invention is in the form of a vial comprising two parts, one part containing the liquid form and the closure device of this type of vial is adapted to contain the dry part which , when opening the vial, will be released into the vial which contains the liquid part.
[116]Les actifs ainsi conservés présentent une meilleure biodisponibilité et une meilleure stabilité dans le temps. [116] The active ingredients thus preserved exhibit better bioavailability and better stability over time.
[117]Exemple 1 de composition selon l'invention [117] Example 1 of composition according to the invention
[Tableau 1]
Figure imgf000016_0001
[118]Les vitamines C, Bl, B2, B6 et D3 sont incorporées à la composition sous forme d'une solution. Elles sont présentes en une quantité de 40 mg, 0.80mg, 1.10 mg, 0.70 mg et 5pg respectivement.
[Table 1]
Figure imgf000016_0001
[118] Vitamins C, B1, B2, B6 and D3 are incorporated into the composition in the form of a solution. They are present in an amount of 40 mg, 0.80 mg, 1.10 mg, 0.70 mg and 5pg respectively.
[119]Procédé de fabrication : [119] Manufacturing process:
L'ensemble des composés de chacune des phases liquide et sèche sont mélangés, puis conditionnés dans des fioles telles que décrites dans le brevet EP 2616354. All the compounds of each of the liquid and dry phases are mixed, then packaged in vials as described in patent EP 2616354.

Claims

Revendications [Revendication 1] Produit de combinaison comprenant à titre de substances actives, au moins : (i) de la gelée royale, (ii) de la spiruline, (iii) de la vitamine C, (iv) de la vitamine D3, (v) des vitamines du groupe B (vi) au moins une souche bactérienne pour aider au maintien des défenses naturelles de l'organisme et à retrouver la forme caractérisé en ce que la gelée royale, la spiruline, la vitamine C, la vitamine D3, les vitamines du groupe B ainsi que la souche bactérienne sont administrées sous la forme d'une fiole comprenant Claims [Claim 1] Combination product comprising as active substances at least: (i) royal jelly, (ii) spirulina, (iii) vitamin C, (iv) vitamin D3, ( v) vitamins of group B (vi) at least one bacterial strain to help maintain the body's natural defenses and restore the form characterized in that royal jelly, spirulina, vitamin C, vitamin D3, the vitamins of group B as well as the bacterial strain are administered in the form of a vial comprising
(1) une partie sèche qui comprend: de 20 à 300 mg, de préférence 30 à 100 mg de vitamine C de 0,05 à 8 mg de préférence 0,2 à 6 mg de vitamine B1 de 0,05 à 8 mg de préférence 0,2 à 6 mg de vitamine B2 de 0,05 à 8 mg de préférence 0,2 à 6 mg de vitamine B6 de 0.5 à 20 pg, de préférence 1 à 10 pg de vitamine D3 de 0,5 à 5 milliards d'unités formant colonie, de préférence de 0.75 à 2 milliards d'unités formant colonie de souche bactérienne (1) a dry part which comprises: from 20 to 300 mg, preferably 30 to 100 mg of vitamin C from 0.05 to 8 mg, preferably 0.2 to 6 mg of vitamin B1 from 0.05 to 8 mg of preferably 0.2 to 6 mg of vitamin B2 from 0.05 to 8 mg preferably 0.2 to 6 mg of vitamin B6 from 0.5 to 20 pg, preferably 1 to 10 pg of vitamin D3 from 0.5 to 5 billion colony forming units, preferably 0.75 to 2 billion bacterial strain colony forming units
(2) une partie liquide qui comprend : de 50 à 500 mg, de préférence de 100 à 300 mg de gelée royale de 50 à 500 mg, de préférence de 100 à 300 mg de spiruline [Revendication 2] Produit de combinaison selon larevendicationl caractérisé en ce que la souche bactérienne est une bactérie lactique, plus préférentiellement du genre Lactobacillus rhamnosus. (2) a liquid part which comprises: from 50 to 500 mg, preferably from 100 to 300 mg of royal jelly from 50 to 500 mg, preferably from 100 to 300 mg of spirulina [Claim 2] Combination product according to claiml characterized in that the bacterial strain is a lactic acid bacterium, more preferably of the genus Lactobacillus rhamnosus.
[Revendication 3] Produit de combinaison selon l'une des revendications précédentes caractérisé en ce que le milieu physiologiquement acceptable est adapté à l'administration par voie orale. [Claim 3] Combination product according to one of the preceding claims, characterized in that the physiologically acceptable medium is suitable for oral administration.
[Revendication 4] Produit de combinaison selon l'une au moins des revendications précédentes, pour la prévention et/ou le traitement des pathologies infectieuses. [Claim 4] Combination product according to at least one of the preceding claims, for the prevention and / or treatment of infectious pathologies.
PCT/EP2020/071443 2019-08-06 2020-07-29 Combination product for helping maintain the natural defenses of the organism and aiding with recovery WO2021023600A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1908999A FR3099698B1 (en) 2019-08-06 2019-08-06 Combination product to help maintain the body's natural defenses and get back in shape
FRFR1908999 2019-08-06

Publications (1)

Publication Number Publication Date
WO2021023600A1 true WO2021023600A1 (en) 2021-02-11

Family

ID=69104574

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2020/071443 WO2021023600A1 (en) 2019-08-06 2020-07-29 Combination product for helping maintain the natural defenses of the organism and aiding with recovery

Country Status (2)

Country Link
FR (1) FR3099698B1 (en)
WO (1) WO2021023600A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3121351B1 (en) * 2021-03-30 2024-03-08 Axeen Pharma Composition based on spirulina and its uses for strengthening immunity

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004100896A2 (en) * 2003-05-13 2004-11-25 Giampapa Vincent C Anti-aging nutritional supplement
EP2616354A1 (en) 2010-09-17 2013-07-24 Biofarma SPA Closing device for a container and container comprising said closing device
US20140308248A1 (en) * 2011-09-14 2014-10-16 Vincent C. Giampapa Dietary Supplement System for Multifunctional Anti-Aging Management and Method of Use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004100896A2 (en) * 2003-05-13 2004-11-25 Giampapa Vincent C Anti-aging nutritional supplement
EP2616354A1 (en) 2010-09-17 2013-07-24 Biofarma SPA Closing device for a container and container comprising said closing device
US20140308248A1 (en) * 2011-09-14 2014-10-16 Vincent C. Giampapa Dietary Supplement System for Multifunctional Anti-Aging Management and Method of Use

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "GREENS+ - Superfood powder for great health", INTERNET CITATION, 1 January 2002 (2002-01-01), pages 1 - 17, XP002566318, Retrieved from the Internet <URL:http://organicpharmacy.org/products/Greens,/SKU:GP10000> [retrieved on 20100129] *
BLINKOVA L P ET AL: "BIOLOGICAL ACTIVITY OF SPIRULINA PLATENSIS", ZURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII,, no. 2, 1 March 2001 (2001-03-01), pages 114 - 118, XP008012772, ISSN: 0372-9311 *
FRATINI FILIPPO ET AL: "Royal Jelly: An ancient remedy with remarkable antibacterial properties", MICROBIOLOGICAL RESEARCH, FISCHER, JENA, DE, vol. 192, 23 June 2016 (2016-06-23), pages 130 - 141, XP029740450, ISSN: 0944-5013, DOI: 10.1016/J.MICRES.2016.06.007 *
JULIO VILLENA ET AL: "Orally administered Lactobacillus rhamnosus modulates the respiratory immune response triggered by the viral pathogen-associated molecular pattern poly(I:C)", BMC IMMUNOLOGY, BIOMED CENTRAL, LONDON, GB, vol. 13, no. 1, 18 September 2012 (2012-09-18), pages 53, XP021115221, ISSN: 1471-2172, DOI: 10.1186/1471-2172-13-53 *
KEN YOSHII ET AL: "Metabolism of Dietary and Microbial Vitamin B Family in the Regulation of Host Immunity", FRONTIERS IN NUTRITION, vol. 6, 17 April 2019 (2019-04-17), XP055689678, DOI: 10.3389/fnut.2019.00048 *
MARIANGELA RONDANELLI ET AL: "Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds-Practical Advice on Dosages and on the Time to Take These Nutrients/Botanic", EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, vol. 2018, 1 January 2018 (2018-01-01), US, pages 1 - 36, XP055689662, ISSN: 1741-427X, DOI: 10.1155/2018/5813095 *

Also Published As

Publication number Publication date
FR3099698B1 (en) 2022-07-08
FR3099698A1 (en) 2021-02-12

Similar Documents

Publication Publication Date Title
JP4594894B2 (en) Composition effective for improving liver function, reducing blood alcohol and antioxidants
NO323353B1 (en) Sports drink including micronutrients and viable lactobacilli
ES2955922T3 (en) Procedure to select a probiotic
WO2014166960A1 (en) Composition comprising a combination of an elder extract and a strain of lactobacillus rhamnosus
ES2925635T3 (en) Oleuropein bioconversion
WO2021023600A1 (en) Combination product for helping maintain the natural defenses of the organism and aiding with recovery
KR20110119305A (en) A functional beverage comprising taurine, royal jelly, red ginseng, lycii fructus, glumate and apple essence as main ingredients
EP2919592B1 (en) Use of branched maltodextrins for the intestinal well-being of infants
JP2006197911A (en) Health food using bee larva
EP2994100A1 (en) Petroselinic acid or a combination of active ingredients comprising at least petroselinic acid for promoting weight loss and/or weight maintenance
US20040254095A1 (en) Supplement for treating musculoskeletal disorders
EP3989995A1 (en) Combination product for helping maintain the natural defenses of the organism
JP2009240308A (en) METHOD FOR PRODUCING MATERIAL CONTAINING Gamma-AMINOBUTYRIC ACID IN HIGH CONTENT
WO2020260500A1 (en) Combination product for helping maintain the natural defenses of the organism
WO2012017363A1 (en) Effervescent solid galenic forms for animals
WO2023006858A1 (en) Combination product for helping maintain the body&#39;s natural defenses, protecting cells from oxidative stress and reducing fatigue
FR2877844A1 (en) Infantile composition used e.g. as infantile food, comprises a probiotic (nonpathogenic strain of Saccharomyces genus), a mixture of nutrients (proteins or amino acids, lipids and carbohydrates) and a mixture of minerals comprising sodium
WO2021116188A1 (en) Combination product contributing to the well-being of pregnant women, comprising epa, dha, vitamins and minerals
WO2023006854A1 (en) Combination product to help regain fitness
WO2019037829A1 (en) Combination product that helps regain fitness
WO2021005310A1 (en) Composition for the treatment of emotional disorders
WO2024022778A1 (en) Combination product comprising active substances suitable for adult requirements
JP2003159029A (en) Health food
KR20170014237A (en) Fermented black garlic and black onion comprising jellystick and Preparation Method Thereof
WO2023144289A1 (en) Use of a mixture of flavanols to increase the concentration of the active form of vitamin d, calcitriol

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20744084

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20744084

Country of ref document: EP

Kind code of ref document: A1